Clinical trial

Triple Therapy in T1DM

NCT03899402

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-05-01

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2019-05-01Date precision: day

Registry last updated2026-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

Placebo to DapagliflozinDRUG

Sponsors & collaborators

State University of New York at Buffalolead sponsor

University of Glasgowcollaborator

Juvenile Diabetes Research Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03899402 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.